Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression

Acevedo-Diaz, Elia E., Cavanaugh, Grace W., Greenstein, Dede, Kraus, Christoph, Kadriu, Bashkim, Zarate, Carlos A., Park, Lawrence T.·2020·Journal of Affective Disorders
DOI 10.1016/j.jad.2019.11.028

Cited by (114)

Items 101–114 of 114

  1. Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression
    Navy Coggins, Hanson A. Chokr, Tricia A. Meyer, Mihir Patel, Sahar Shekoohi, Alan D. Kaye · 2026 · Current Pain and Headache Reports
  2. Yueju pill exerts rapid antidepressant effects via sequential activation of hippocampal GLP-1 receptor and PACAP signaling in mice
    Shan Xing, Yuhan Peng, Yanqin Wang, Changyu Wu, Mingzhi Han, Huijun Xie, Gang Chen, Hailou Zhang · 2026 · Journal of Ethnopharmacology
  3. Comparative network pharmacology analysis of ketamine and xanomeline in major depressive disorder: Shared and distinct molecular mechanisms
    Xin Ding, Kenji Hashimoto, Jian-Jun Yang · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  4. Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies
    R. Crawford Morris, Ayse Gundogan, Vanessa C. Lawrence, Hubertus Himmerich, Janet L. Treasure, Johanna Louise Keeler · 2026 · BMC Medicine
  5. Muscone Exerts Rapid Antidepressant Effects Through Modulating Glutamatergic Neural Transmission in the Anterior Cingulate Cortex Against Peripheral Inflammation-induced Depression
    Xiaoyun Qiu, Xiaojie Zhang, Yuanzhi Yang, Minjuan Sun, Xiaoli Da, Jiaying Liu, Rui Wang, Jingjia Liang, Xuhong Jiang, Gang Tian et al. · 2026 · Neuroscience Bulletin
  6. Effect of intraoperative ketamine on pain, opioid use, and psychological recovery in orthopedic trauma patients (KOPM trial): protocol for a randomized, single-blind trial
    Camas Curran, Evan J. Hernandez, Jennifer Hudnall, Jaspinder Sra, Max E. Davis · 2026 · Pain Management
  7. Treating addiction with an addictive drug: the ketamine paradox revisited
    Alqassem Y. Hakami · 2026 · Frontiers in Psychiatry
  8. Ketamine for substance use disorders: a systematic review and meta-analysis
    Shu-Ping Fang, Xin Yang, Da-Cong Zhao, Yang Wen, Yi-Hao Liu, Zhe Li, M. Ran · 2026 · Frontiers in Psychiatry
  9. Ketamine and Its Enantiomer(s) Therapy to Treat Major Depressive Disorder: Clinical Relevance and Underlying Mechanisms
    Joel Kallarackal, Brandon J. Dyer, Jeffrey Huang · 2026 · Springer eBooks
  10. Ketamine-Induced Dissociation as an Ethical Signal, Not a Side Effect: Context as the Determinant of Clinical Duties Under Beneficence and Non-maleficence
    Gun Moon, Jack Noto, Zachary Shuler, Bryan Pilkington · 2026 · HEC Forum
  11. Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey
    Omer A. Syed, Rotem Petranker, Sean M. Nestor, Muhammad Ishrat Husain, Nir Lipsman, Fahad Alam, Peter Giacobbe, Stephanie Lake, Philippe Lucas · 2026 · Journal of Psychoactive Drugs
  12. Multimodal predictors of response to intravenous ketamine in treatment-resistant depression: toward personalized treatment in major depressive and bipolar disorders
    Magda Malewska-Kasprzak, Filip Rybakowski, Monika Dmitrzak‐Węglarz · 2026 · CNS Spectrums
  13. Antidepressants and cognitive function in major depressive disorder: Mechanisms, clinical evidence, and implications for precision treatment
    Yao Liu, Yunfei Tan, Kenji Hashimoto · 2026 · European Journal of Pharmacology
  14. BindingDB Entry 50011888: Repurposing of Drugs-The Ketamine Story.
    BindingDB · 2022 · UC San Diego